Meanwhile, the company has a free GLP-1 Supply Tracker that patients can use to receive crowdsourced information about local shortages in their area
The guidelines warn, however, that GLP-1 receptor agonist therapy is not indicated for all patients and should be used with caution in patients with a history of significant gastrointestinal disease, such as a diagnosis of gastroparesis, due to a possible exacerbation of the condition with incretin mimetic therapy
What to Know About Retatrutide
If $299 or $399 per month is not sustainable for your financial situation, starting at the introductory rate and then struggling to continue is worse than choosing a different option from the beginning
Diarrhea and Constipation Some patients develop diarrhea , while others experience constipation due to changes in digestive motility
How effective is Retatrutide